Breathing Training for Asthma

Completed · Not applicable

Conditions studied: ASTHMA

In brief

For the proposed randomized controlled treatment study, the investigators plan to compare the effects of this hypoventilation-based breathing training with a control intervention that will focus on breathing regularity and awareness. The two therapeutic procedures are closely matched on important variables such as duration and the nature of patient-therapist interaction, monitoring asthma related status and the medication intake, use of scientific equipment and monitoring devices to increase adherence, and initial plausibility. Asthma patients who will be evaluated before, during, directly after, and at 2 months and 6 months after training.

Key facts

Study ID

NCT00975273

Run by

Southern Methodist University

People needed

120

Starts

2008-07-01

Expected to finish

2013-07-01

Last updated by the study team

2018-06-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men or women between 18 and 65 years of age
• Understand and read english adequately
• A previously documented history of asthma from intermittent to severe (symptoms plus objective documentation of at least partially reversible airflow obstruction)
• Willing to undergo a 5-session course of breathing training
• Current asthma symptoms

You may not qualify if…

• Clinically significant heart disease
• Clinically significant cerebrovascular disease
• Clinically significant thyroid dysfunction
• Out-of-control diabetes
• Use of oral corticosteroids in the last 3 months
• Active smokers or more than 10 pack years
• Clinically significant chronic obstructive pulmonary disease
• Clinically significant emphysema
• Current alcohol and substance dependence
• Psychotic disorders and high risk for personality disorders
• Having received previous breathing training exercises for asthma
• Not willing to abstain from taking the morning dose of their long-term bronchodilator or leukotriene inhibitors or from using their short-acting beta-2 adrenergic agonists or anticholinergic bronchodilators for 8 hours before the pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up assessments (Medication withdrawal will be discouraged if patients should experience significant symptoms before the assessments. They will be offered to reschedule the appointment without any consequences for their enrollment in the study.)
• Night shift workers
• Tuberculosis
• Pregnant, plan on becoming pregnant, or nursing during the course of the study

Where it is running

• Baylor University Medical Center (BUMC) — Dallas, Texas, United States
• Southern Methodist University (SMU) — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.